• Fri news: New Novo obesity prospect linked to psychiatric side effects. Summit beats Keytruda in NSCLC. DermaSensor skin cancer detection device. Astellas digital health product. Sanofi MS data. See more on our front page

FDA warns diagnostic maker for failing to seek approval for changes, OTC firm for lax...

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Apr 21, 2023 at 12:02: AM
via The US Food and Drug Administration (FDA) recently sent warning letters to a subsidiary of device manufacturer Abbott and to an over-the-counter (OTC) drugmaker following inspections in 2022.

article source
 

<



Similar threads

cafead
FDA warns of potential risk from Hologic&#039;s devices implanted in soft tissue
Replies
0
Views
140
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
FDA warns providers not to buy or implant Synovo’s total hip system
Replies
0
Views
204
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
FDA warns about counterfeit versions of Novo&#039;s diabetes drug Ozempic
Replies
0
Views
357
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
FDA warns manufacturers to test for contaminants tied to global deaths
Replies
0
Views
91
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
FDA warns CVS, Walgreens, other companies over unapproved eye products
Replies
0
Views
189
Pharma/Biotech Companies - In the News
cafead
cafead
Top Bottom
Back
Quote